FOLH1 and cancer: On the other hand, although nonprostatic PSMA uptake might hamper the diagnostic performance of PSMA PET imaging, the receptor expression observed in some malignant tumor cells broadens the application of its use in diagnosis or even therapeutic approaches using PSMA-targeted radionuclide therapy [4].